Search
for

    Sort by

    Research 331–360 of 661

    1. Relationship of Serum Prostate Specific Antigen with Hirsutism in Women Having Polycystic Ovary Syndrome Belonging to the Province of Khyber Pakhtunkhwa, Pakistan Journal of Liaquat University of Medical & Health Sciences · 2023
    2. Prostate Specific Antigen as Predictive Factor for Androgenemia in Women Indian Journal of Forensic Medicine & Toxicology · 2022
    3. Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient Diabetes Therapy · 2022
    4. Addressing Autoimmune and Immune-mediated Skin Disease Burden in Women Women's health issues · 2022
    5. 테스토스테론으로 유도된 전립선 비대증에 대한 Sapium rotundifolium Hemsl. 추출물의 효과 KMOU Repository (Korea Maritime and Ocean University) · 2019
    6. PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL The Journal of Urology · 2019
    7. Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial European Urology Supplements · 2019
    8. Efecto del extracto hidroetanólico de semillas de Coffea arabica L. sobre la hiperplasia prostática inducida en Mus musculus var. swiss orquiectomizados Universidad Nacional de Trujillo · 2017
    9. The Relationship between Androgenic Alopecia and Prostate Cancer International Journal of Medical Research and Health Sciences · 2016
    10. Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata 2015
    11. Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life Cancer research · 2015
    12. 피나스테라이드의 특성에 대한 이론적 연구 한국산업융합학회 논문집 · 2013
    13. 1746 INCREASED SERUM C-REACTIVE PROTEIN LEVELS IMPLIES CHRONIC INFLAMMATION IS INVOLVED IN MEN WITH BENIGN PROSTATIC HYPERPLASIA AND PREDOMINANT STORAGE LOWER URINARY TRACT SYMPTOMS The Journal of Urology · 2013
    14. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    15. 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY The Journal of Urology · 2012
    16. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    17. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    18. DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP The Journal of Urology · 2009
    19. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    20. The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH Journal of Jilin Medical College · 2009
    21. 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향 생약학회지 · 2007
    22. Editorial comment 1 Urology · 2004
    23. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Open MIND · 2026
    24. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Research Square (Research Square) · 2023
    25. Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele Cancer Causes & Control · 2017
    26. 1378 CHARATERISTICS OF PATIENTS ON NON-DAILY AND DAILY DUTASTERIDE COMPARED TO PATIENTS CYTOREDUCTION NAIVE The Journal of Urology · 2013
    27. Management of Advanced Prostate Cancer Undergoing Major Shift Oncology times · 2011
    28. S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8) European Urology Supplements · 2009
    29. PCPT Results Could Affect Trial on Testosterone Replacement Oncology Times · 2003
    30. IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA Zenodo (CERN European Organization for Nuclear Research) · 2023